Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125531081 | 12553108 | 1 | I | 20160630 | 20160713 | 20160713 | EXP | US-DRREDDYS-USA/USA/16/0081390 | DR REDDYS | TRASAR L, MIRZA N, LISAWAT P, RAUT R, SHIH W. THROMBOTIC THROMBOCYTOPENIC PURPURA AND RHABDOMYOLYSIS ASSOCIATED WITH CIPROFLOXACIN USE. AM J KIDNEY DIS. 2016;67(5):A109. | 56.00 | YR | M | Y | 0.00000 | 20160713 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125531081 | 12553108 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | Y | UNKNOWN | 75593 | |||||||||
| 125531081 | 12553108 | 2 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | U | UNKNOWN | 77752 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125531081 | 12553108 | 1 | Urinary tract infection |
| 125531081 | 12553108 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125531081 | 12553108 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125531081 | 12553108 | Blood creatinine increased | |
| 125531081 | 12553108 | Rhabdomyolysis | |
| 125531081 | 12553108 | Seizure | |
| 125531081 | 12553108 | Thrombotic thrombocytopenic purpura |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |